Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities
Pediatric Pulmonology · 2024-11 · 59 (11) · 2901-2909
DOI: 10.1002/ppul.27155 ↗At a glance
Journal article in Pediatric Pulmonology, published online on 2024-06-28. Written by Meghan E McGarry and 4 co-authors. Institution: Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Washington, Seattle, Washington, USA. Major MEDLINE topics: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Neonatal Screening. Cited 9 times so far (Crossref); 38 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, NIMHD NIH HHS, Cystic Fibrosis Research Institute.
Abstract (original language)
Background
Newborn screening (NBS) for cystic fibrosis (CF) is universal in the United States. Protocols vary but include an immunoreactive trypsinogen (IRT) level and CFTR variant panel. California CF NBS has a 3‐step screening: IRT level, variant panel, and CFTR sequencing if only one variant identified on panel.
Methods
This was a cohort study of infants with CF born in California (2007−2021) to examine racial and ethnic differences in having a false‐negative NBS result for CF and at which step the false‐negative occurred. We examined how different CFTR variant panels would improve detection of variants by race and ethnicity: original 39‐variant panel, current 75‐variant panel, and all 402 disease‐causing CFTR variants in the CFTR2 database.
Results
Of the 912 infants born in California with CF, 84 had a false‐negative result: 38 due to low IRT level and 46 with a high IRT value (but incomplete variant detection). Asian (OR 6.3) and Black infants (OR 2.5) were more likely to have a false‐negative screening result than non‐Hispanic white infants. The majority of false‐negative screening (but CF diagnosis) cases among American Indian/Native Alaskan and non‐Hispanic White infants were due to low IRT levels. The majority of Asian and Hispanic infants with false‐negative screening had no variants detected. Detection of two CFTR variants was improved with the 75‐variant panel in Black, Hispanic, and non‐Hispanic White infants and with the 402‐variant panel in Black, Hispanic, non‐Hispanic White, and other race infants.
Conclusions
Larger CFTR panels in NBS improved the detection of CF in all races and ethnicities.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Washington, Seattle, Washington, USA.
- Center for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
- California Department of Public Health, Genetic Disease Screening Program, Richmond, California, USA.
- Department of Pediatrics, Division of Pulmonary Medicine, University of California San Francisco, San Francisco, California, USA.
ORCID profiles: Meghan E McGarry, Stanley Sciortino
Funding
- NHLBI NIH HHS
- NIMHD NIH HHS
- Cystic Fibrosis Research Institute
- National Heart, Lung, and Blood Institute
Cite
APA
McGarry, M. E., Sciortino, S., Graham, S., Bishop, T., & Gibb, E. R. (2024). Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities. Pediatric Pulmonology, 59(11), 2901-2909. https://doi.org/10.1002/ppul.27155
Vancouver
McGarry ME, Sciortino S, Graham S, Bishop T, Gibb ER. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities. Pediatric Pulmonology. 2024;59(11):2901-2909. doi:10.1002/ppul.27155
BibTeX
@article{McGarry2024,
author = {McGarry, Meghan E and Sciortino, Stanley and Graham, Steve and Bishop, Tracey and Gibb, Elizabeth R},
title = {Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities},
journal = {Pediatric Pulmonology},
year = {2024},
volume = {59},
number = {11},
pages = {2901--2909},
doi = {10.1002/ppul.27155}
}
EUVIMED